References
1. Bonow RO, Nishimura RA, Thompson PD, Udelson JE. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities : Task Force 5 : Valvular Heart Disease American College of Cardiology. Circulation. 2015;292–7.
2. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Corrado D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;1422–45.
3. Basso C, Marra MP, Rizzo S, De Lazarri M, Giorgi B, Cipriani A, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation.2015; 132(7):556-66
4. Marra MP, Basso C, Lazzari M De, Rizzo S, Cipriani A, Giorgi B, et al. Valvular Heart Disease Morphofunctional Abnormalities of Mitral Annulus and. Cir Cardiovasc Imaging.2016; 9(8): e005030
5. Pradella S, Grazzini G, Brandani M, Calistri L, Nardi C, Mori F, et al. Cardiac magnetic resonance in patients with mitral valve prolapse : Focus on late gadolinium enhancement and T1 mapping. Eur Radiol. 2019; 29(3):1546-1554
6. Gati S, Malhotra A, Sharma S. Exercise recommendations in patients with valvular heart disease. Heart. 2019; 105(2):106-110.
7. Arcy JLD, Syburra T, Guettler N, Davenport ED, Manen O, Gray G, et al. Contemporaneous management of valvular heart disease and aortopathy in aircrew. 2019; Heart. 2019 ;105(Suppl 1):s57-s63
Notes to editor
Author information:
María Sanz-de la Garza MD, PhD, Laura Sanchis, MD, PhD , Marc Abuli, Marta Sitges, MD, PhD. For all authors: Cardiovascular Institute, Hospital Clinic, Barcelona






